WebInformation on acquisition, funding, cap tables, investors, and executives for Kintai Therapeutics. Use the PitchBook Platform to explore the full profile. Request a free trial … WebKintai Therapeutics's main competitors include Rexgenero, Cook MyoSite, Cord Blood Registry and GentiBio. Compare Kintai Therapeutics to its competitors by revenue, …
Kintai Therapeutics Company Profile: Acquisition & Investors
Web14 apr. 2024 · Aer Therapeutics, a Raleigh, North Carolina-based biopharmaceutical company developing novel inhaled treatments for muco-obstructive lung diseases, raised $36M in Series A funding.. Backers ... Web27 aug. 2024 · CAMBRIDGE, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Kintai Therapeutics, a Flagship Pioneering company, today announced that it has established new collaborations with leading academic... bitters with ginger
Kintai Therapeutics - Crunchbase Company Profile
WebKintai Therapeutics is a company that aims to treat diseases and restore the health of patients using the enteric signaling network. Its Precision Enteric Medicine (PEM) discovery and therapeutic platform is based on the interconnected biology of the microbiome, gut immune system, and enteric nervous system. Web22 jan. 2024 · Flagship Pioneering portfolio company Kintai Therapeutics said it is moving its anti-obesity drug candidate KTX-0200 into IND-enabling studies after rodent studies returned positive results. In ... WebKintai Therapeutics Overview. Founded Year 2024. Location Cambridge, United States. Company Stage Funding Raised. Similar Cos. Finch Therapeutics, Ironwood Pharma, RedHill Biopharma, Evolve Biosystems, Novome Biotechnologies & 106 others. Let us walk you through our Companies Database and other offerings. bitters with lemon juice and sugar